PMV Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Pmv Pharmaceuticals

10/05/2023 13:50

* PMV Pharmaceuticals Inc  PMVP.OQ  reported a quarterly
adjusted
loss of 42 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 46 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * PMV Pharmaceuticals Inc's reported EPS for the quarter was
a
loss of 42 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * PMV Pharmaceuticals Inc shares had risen by 5.7% this
quarter and lost 42.1% so far this year.
    * The company reported a quarterly loss of $19.13 million.
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $19.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 12:50 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.46          -0.42          Beat
 Dec. 31 2022      -0.44          -0.43          Beat
 Sep. 30 2022      -0.42          -0.40          Beat
 Jun. 30 2022      -0.41          -0.38          Beat